目标:在未选择的普通人群中(n=1.668),研究了超过所有来源的膳食咖啡因摄入量的预后影响。
结果:冠状动脉事件的预后临界值,心力衰竭(HF),通过受试者工作特征曲线法发现脑血管事件(CBV)和心律失常事件(ARR).那些用于HF(>230毫克/天),CBV(>280毫克/天)和ARR(>280毫克/天)在校正年龄的多变量Cox分析中得到证实,身体质量指数,循环甲状腺激素,糖尿病,动脉高血压,吸烟,饮食摄入乙醇,基础心率,低密度脂蛋白胆固醇,1s用力呼气容积和β-阻断治疗。在整个队列的随访期间,超过这些临界值与风险比降低相关(HF的HR0.678,95CI0.567-0.908,p=0.009;0.651,95CI0.428-0.994,CBV的p=0.018;0.395,95CI0.395-0.933,ARR的p=0.022)和男性(0.652,0.442-0.53,p=0.53,女性,p=0.因此,在整个队列中观察到的咖啡因诱导的风险降低完全归因于男性。在HF的情况下,在不拒绝咖啡因的情况下,心率以积极的方式进入风险方程。CYP1A2基因的-163C>A多态性,编码代谢咖啡因的能力,在敏感性分析中引入,没有改变预后模型。
结论:男性摄入>230毫克/天的咖啡因可降低HF的风险,和那些引入>280毫克/天的CBV和ARR的风险降低,而不依赖于遗传模式。
OBJECTIVE: Among an unselected cohort of men and women from general population (n = 1.668), the prognostic effects of being over the cut-off of all-source dietary caffeine intake were studied.
RESULTS: Prognostic cut-off values for coronary events, incident heart failure (HF), cerebrovascular events (CBV) and arrhythmic events (ARR) were found by means of the receiver-operating-characteristic curves method. Those for HF (>230 mg/day), for CBV (>280 mg/day) and for ARR (>280 mg/day) were confirmed in multivariate Cox analysis adjusted for age, body mass index, circulating thyroid hormone, diabetes mellitus, arterial hypertension, smoking, dietary intake of ethanol, basal heart rate, low-density-lipoprotein cholesterol, forced expiratory volume in 1 s and β-blocking therapy. Being over these cut-off values was associated to a reduced hazard ratio during the follow-up in the whole cohort (HR 0.678, 95%CI 0.567-0.908, p = 0.009 for HF; 0.651, 95%CI 0.428-0.994, p = 0.018 for CBV; 0.395, 95%CI 0.395-0.933, p = 0.022 for ARR) and in men (0.652, 0.442-0.961, p = 0.029; 0.432, 0.201-0.927, p = 0.03; 0.553, 0.302-1.000, p = 0.05, respectively) but not in women. The caffeine-induced risk decrease observed in the whole cohort is therefore entirely attributable to men. In the case of HF, heart rate entered the risk equation in a positive manner without rejecting caffeine. The -163C>A polymorphism of the CYP1A2 gene, codifying for ability to metabolize caffeine, introduced in sensitivity analysis, did not alter the prognostic models.
CONCLUSIONS: Men introducing >230 mg/day caffeine show a reduced risk of HF, and those introducing >280 mg/day a reduced risk of CBV and ARR independent of genetic pattern.